These results are consistent with prior studies showing that the downregulation of OGA results in the activation of Akt1 in thyroid anaplastic cells [86] and that O-GlcNAcylation enhances anaplastic thyroid carcinoma malignancy [87]. The gene discussed is AKT1; the disease is thyroid gland undifferentiated (anaplastic) carcinoma.